Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Guilherme Jorge Costa"'
Autor:
Guilherme Jorge Costa, José Roberto da Silva Junior, Caio Cesar Arruda da Silva, Tiago Pessoa Ferreira de Lima, Mariana Menezes Costa, Marcos Henrique Oliveira Sousa, Gabriela Carla dos Santos Costa, José Iran Costa Júnior, Mozart Júlio Tabosa Sales
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 49, Iss 4 (2023)
ABSTRACT Objective: To determine the clinical profile of COVID-19 inpatients who were vaccinated prior to hospitalization and to compare the risk factors for death and the 28-day survival rate of between those inpatients vaccinated with one, two, or
Externí odkaz:
https://doaj.org/article/9710d7977f8e4661a2b2fb80e47adc2e
Autor:
Donato da Silva Braz Junior, Guilherme Jorge Costa, Nathália Alves de Barros e Lyra, Mirela Muniz Arantes Viana, Vinícius Santos Borba, Luiz Claudio Santos Thuler, Eduardo Jorge da Fonseca Lima, Maria Júlia Gonçalves de Mello
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 48, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/586b4befafee49cb80d56b4232f7115c
Autor:
Guilherme Jorge Costa, Maria Júlia Gonçalves de Mello, Anke Bergmann, Carlos Gil Ferreira, Luiz Claudio Santos Thuler
Publikováno v:
Jornal Brasileiro de Pneumologia
ABSTRACT Objective: To characterize the clinical and histological profile, as well as treatment patterns, of patients with early-stage, locally advanced (LA), or advanced/metastatic (AM) lung cancer, diagnosed between 2000 and 2014, in Brazil. Method
Externí odkaz:
https://doaj.org/article/c4b410780de041469bdea80f5ddd4312
Autor:
Maria Júlia Gonçalves de Mello, Luiz Claudio Santos Thuler, Gustavo Telles da Silva, Guilherme Jorge Costa, Carlos Gil Ferreira, Anke Bergmann
Publikováno v:
Clinical Lung Cancer. 22:e313-e319
Lung cancer is the principal cause of cancer-related deaths worldwide; however, there has been controversy as to whether there is a difference in survival rate according to gender in Brazil. The aim of the present study, therefore, was to compare the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae9d400bbb91ab6243153e181707ca7e
https://doi.org/10.1016/j.cllc.2020.05.022
https://doi.org/10.1016/j.cllc.2020.05.022
Autor:
Luiz Claudio Santos Thuler, Maria Júlia Gonçalves de Mello, Donato da Silva Braz Júnior, Vinícius Santos Borba, Mirela Muniz Arantes Viana, Guilherme Jorge Costa, Nathália Alves de Barros e Lyra
Publikováno v:
Respirology. 26:1085-1087
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0b08283b40bca28396167b91a0609ad
https://doi.org/10.1111/resp.14164
https://doi.org/10.1111/resp.14164
Autor:
Guilherme Jorge Costa, Guilherme Vieira Mendonça Filho, Leuridan Cavalcante Torres, Dulce Elena Casarini
Background: The immune system is recognized to have therapeutic potential to destroy cancer cells. T-cell immunoglobulin mucin domain-3 (sTIM-3) and its ligand galectin 9 (GAL9) cause suppression of cytokine production, cell cycle arrest, and cell de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::984c97eb9bdc5e1015f3b51a364fb2b1
https://doi.org/10.21203/rs.3.rs-1339051/v1
https://doi.org/10.21203/rs.3.rs-1339051/v1
Autor:
Luiz Claudio Santos Thuler, José Iran Costa Júnior, Carla Rameri Alexandre Silva de Azevedo, Anke Bergmann, Guilherme Jorge Costa
Publikováno v:
Cancer
BACKGROUND Coronavirus disease 2019 (COVID‐19) and cancer are serious public health problems worldwide. However, little is known about the risk factors of in‐hospital mortality among COVID‐19 patients with and without cancer in Brazil. The obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b17be4e1328072967a3d9bd7cb48fb4
http://europepmc.org/articles/PMC8426714
http://europepmc.org/articles/PMC8426714
Autor:
Guilherme Jorge Costa, Isabella Favato Barcelos, Gabriela Monte Tenorio Taveira, Pedro De Marchi, Tatiane Caldas Montella, Luiz Claudio Santos Thuler, Carlos G. M. Ferreira
Publikováno v:
Journal of Clinical Oncology. 40:e20597-e20597
e20597 Background: malignant mesothelioma is a rare tumor with about 31,000 new cases diagnosed annually worldwide. Malignant pleural mesothelioma (MPM) is recognized as an occupational cancer, and past exposure to asbestos represents its main risk f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::356fcc6c5591cf9d0b070826f9783479
https://doi.org/10.1200/jco.2022.40.16_suppl.e20597
https://doi.org/10.1200/jco.2022.40.16_suppl.e20597
Autor:
Guilherme Jorge Costa, Hélio de Araújo Fonseca Júnior, Fábio Costa Malta, Felipe Costa Leandro Bitu, Claudia Barbosa, Josenildo de Sá, André Amarante, Luiz Claudio Santos Thuler
Publikováno v:
Seminars in oncology. 49(2)
Patients with cancer need to receive their proper treatment and often cannot wait for their treatment, despite delays due to the COVID-19 pandemic. As a result, many cancer centers have had challenges maintaining their oncological activities.To compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6a69a5e5c7597e20a4b6de5b9f5c2c
https://pubmed.ncbi.nlm.nih.gov/35606169
https://pubmed.ncbi.nlm.nih.gov/35606169
Publikováno v:
Lung Cancer. 97:66-72
Objectives Regarding the fatality rates stemming from various existing forms of cancers worldwide, lung cancer (LC) is ranked as the main cause of death amongst those who suffer from cancer. Although the epidemiological, clinical, and histological pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4e4a507cd66ef0fddf3cbbc34508486
https://doi.org/10.1016/j.lungcan.2016.04.019
https://doi.org/10.1016/j.lungcan.2016.04.019